Form 4: Accuray Director Granted 56,603 Restricted Stock Units

Accuray Inc. Director Byron C Scott received a grant of 56,603 Restricted Stock Units on November 28, 2025, which will vest in November 2026.

Summary

• Byron C Scott, a Director of Accuray Inc. (ARAY), was granted 56,603 Restricted Stock Units (RSUs).
• The transaction date for this grant was November 28, 2025.
• Each RSU represents a contingent right to receive one share of Accuray's common stock.
• The RSUs will vest 100% on November 13, 2026.
• Following this transaction, Byron C Scott beneficially owns 56,603 derivative securities (RSUs) directly.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as the equity grant aligns the director's interests with shareholders, which is generally viewed favorably. However, it is a routine compensation event and not indicative of significant operational or financial news.

Positives

• The grant of Restricted Stock Units to a director helps align management's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.

Future Outlook

This filing does not contain forward-looking statements or guidance beyond the vesting schedule of the granted Restricted Stock Units.

Industry Context

The grant of Restricted Stock Units is a common form of equity compensation for directors and executives across various industries, used to attract, retain, and incentivize key personnel by linking their compensation to the company's long-term performance.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a form of director compensation is a standard practice within the healthcare technology and medical device sectors, similar to companies like Intuitive Surgical (ISRG) or Medtronic (MDT) which frequently utilize equity grants to align director and executive interests with shareholder value.
• The vesting schedule, with a 100% vest on a future date, is also a common structure designed to promote long-term commitment and performance.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with the long-term performance of the company, potentially encouraging decisions that enhance shareholder value.

Next Steps

• The Restricted Stock Units will vest on November 13, 2026, at which point they will convert into shares of Accuray Inc. common stock.

Key Dates

Keywords

Accuray Inc., ARAY, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Insider Transaction, Byron C Scott, SEC Form 4